Search details
1.
Virus-induced senescence is a driver and therapeutic target in COVID-19.
Nature
; 599(7884): 283-289, 2021 11.
Article
in English
| MEDLINE | ID: mdl-34517409
2.
Revised ISHAM-ABPA working group clinical practice guidelines for diagnosing, classifying and treating allergic bronchopulmonary aspergillosis/mycoses.
Eur Respir J
; 63(4)2024 Apr.
Article
in English
| MEDLINE | ID: mdl-38423624
3.
Burden, clinical features, and outcomes of post-tuberculosis chronic obstructive lung diseases.
Curr Opin Pulm Med
; 30(2): 156-166, 2024 Mar 01.
Article
in English
| MEDLINE | ID: mdl-37902135
4.
Chronic Pulmonary Aspergillosis as a Considerable Complication in Post-Tuberculosis Lung Disease.
Semin Respir Crit Care Med
; 45(1): 102-113, 2024 Feb.
Article
in English
| MEDLINE | ID: mdl-38196060
5.
[Treatment of MDR, pre-XDR, XDR and rifampicin resistant tuberculosis or in case of intolerance to at least rifampicin in Austria, Germany and Switzerland - Amendment dated 19.09.2023 to the Sk2-Guideline: Tuberculosis in adulthood of the German Central Committee against Tuberculosis (DZK) on behalf of the German Respiratory Society (DGP)]. / Therapie bei MDR-, prä-XDR-, XDR-Tuberkulose und Rifampicin-Resistenz oder bei Medikamentenunverträglichkeit gegenüber mindestens Rifampicin.
Pneumologie
; 78(1): 35-46, 2024 Jan.
Article
in German
| MEDLINE | ID: mdl-37931778
6.
The Austrian landscape of diagnostic capacity and access to treatment for invasive fungal infections.
Mycoses
; 66(12): 1056-1063, 2023 Dec.
Article
in English
| MEDLINE | ID: mdl-37592370
7.
Tuberculosis incidence in foreign-born people residing in European countries in 2020.
Euro Surveill
; 28(42)2023 10.
Article
in English
| MEDLINE | ID: mdl-37855907
8.
Characterization of Treatment Response Outcomes in Chronic Pulmonary Aspergillosis: CPAnet Definitions Versus the Existing Criteria.
Mycopathologia
; 188(5): 721-730, 2023 Oct.
Article
in English
| MEDLINE | ID: mdl-37291204
9.
[National consensus statement by the Austrian Societies for Rheumatology, Pulmonology, Infectiology, Dermatology and Gastroenterology regarding the management of latent tuberculosis and the associated utilization of biologic and targeted synthetic DMARDS (disease modifying antirheumatic drugs)]. / Consensus Statement der Österreichischen Gesellschaften für Rheumatologie und Rehabilitation, Pneumologie, Infektiologie, Dermatologie und Gastroenterologie zum Umgang mit latenter Tuberkulose bei Therapien mit biologischen oder "targeted synthetic" DMARDs ("disease modifying antirheumatic drugs").
Z Rheumatol
; 82(2): 163-174, 2023 Mar.
Article
in German
| MEDLINE | ID: mdl-36342525
10.
qSOFA score poorly predicts critical progression in COVID-19 patients.
Wien Med Wochenschr
; 172(9-10): 211-219, 2022 Jun.
Article
in English
| MEDLINE | ID: mdl-34185216
11.
Rare manifestation of a large stenosing gastrointestinal tumor caused by Mycobacterium tuberculosis in a previously healthy man from Austria.
Wien Med Wochenschr
; 172(11-12): 268-273, 2022 Sep.
Article
in English
| MEDLINE | ID: mdl-34613520
12.
[Tuberculosis in adulthood - The Sk2-Guideline of the German Central Committee against Tuberculosis (DZK) and the German Respiratory Society (DGP) for the diagnosis and treatment of adult tuberculosis patients]. / Tuberkulose im Erwachsenenalter.
Pneumologie
; 76(11): 727-819, 2022 Nov.
Article
in German
| MEDLINE | ID: mdl-36384164
13.
Prediction of anti-tuberculosis treatment duration based on a 22-gene transcriptomic model.
Eur Respir J
; 58(3)2021 09.
Article
in English
| MEDLINE | ID: mdl-33574078
14.
Nontuberculous Mycobacterial Pulmonary Disease from Mycobacterium hassiacum, Austria.
Emerg Infect Dis
; 26(11): 2776-2778, 2020 11.
Article
in English
| MEDLINE | ID: mdl-33079051
15.
Chronic pulmonary aspergillosis update: A year in review.
Med Mycol
; 57(Supplement_2): S104-S109, 2019 Apr 01.
Article
in English
| MEDLINE | ID: mdl-30816975
16.
Case Definition of Chronic Pulmonary Aspergillosis in Resource-Constrained Settings.
Emerg Infect Dis
; 24(8)2018 08.
Article
in English
| MEDLINE | ID: mdl-30016256
17.
A CPAnet consensus statement on research priorities for chronic pulmonary aspergillosis: a neglected fungal infection that requires attention.
J Antimicrob Chemother
; 73(2): 280-286, 2018 02 01.
Article
in English
| MEDLINE | ID: mdl-29126309
18.
Clinical, Diagnostic, and Treatment Disparities between HIV-Infected and Non-HIV-Infected Immunocompromised Patients with Pneumocystis jirovecii Pneumonia.
Respiration
; 96(1): 52-65, 2018.
Article
in English
| MEDLINE | ID: mdl-29635251
19.
Pulmonary Diseases in Refugees and Migrants in Europe.
Respiration
; 95(4): 273-286, 2018.
Article
in English
| MEDLINE | ID: mdl-29414830
20.
Treatment of Chronic Pulmonary Aspergillosis: Current Standards and Future Perspectives.
Respiration
; 96(2): 159-170, 2018.
Article
in English
| MEDLINE | ID: mdl-29982245